Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 1;38(6):294-299.
doi: 10.1097/JMQ.0000000000000154. Epub 2023 Nov 1.

Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting

Emily W Gripp  1 , Bryan D Hess  2 , Adam F Binder  3
Affiliations

Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting

Emily W Gripp et al. Am J Med Qual. .

Abstract

Oncology patients presenting for outpatient evaluation of a respiratory tract infection (RTI) are often tested for a variety of viruses with a respiratory pathogen panel (RPP) in addition to influenza and SARS-CoV-2. This triad of testing is expensive and uncomfortable because it requires 2 nasal swabs. Little evidence supports the use of an RPP in outpatient settings, but it is routinely ordered. This retrospective chart review analyzed 183 RPPs performed at Jefferson between April 2020 and November 2021 in outpatient oncology patients presenting with RTI. Data collected included patient demographics, symptoms, and exam findings at time of RPP, additional testing completed, results of RPP, antibiotic and antiviral use before and after RPP results, and patient outcomes 30 days after RPP. Descriptive statistics were calculated. Of the 183 RPPs analyzed, 16.9% (31) were positive for at least 1 respiratory virus. Fifty-two patients (28.4%) started antibiotics before results of the RPP. Of those, 2 patients (3.8%) had a change in antibiotic plan after RPP results returned. Zero patients were started on antiviral medication before results of the RPP. One patient started antiviral treatment after RPP results returned. In total, only 3 patients (1.6%) had an RPP-driven change in medication management. This study suggests limited utility in use of RPPs for oncology patients presenting to the office with RTI symptoms. Targeted testing with a single nasal swab for influenza, RSV, and SARS-CoV-2 may be more clinically relevant. The authors hope to use these data to implement a quality improvement initiative to reduce RPP utilization in this population.

PubMed Disclaimer

References

    1. Green DA, Hitoaliaj L, Kotansky B, et al. Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol. 2016;54:2950–2955.
    1. Legoff J, Zucman N, Lemiale V, et al. Clinical significance of upper airway virus detection in critically ill hematology patients. Am J Respir Crit Care Med. 2019;199:518–528.
    1. Krantz EM, Zier J, Stohs E, et al. Antibiotic prescribing and respiratory viral testing for acute upper respiratory infections among adult patients at an ambulatory cancer center. Clin Infect Dis. 2020;70:1421–1428.
    1. Smith SM, Pineda ED, Oda J, et al. Outcomes associated with antibiotic cessation in oncology patients with positive respiratory viral panel polymerase chain reaction results. Infect Dis. 2020;28:277–280.
    1. Evans SE, Jennerich AL, Azar MM, et al. Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia. Am J Respir Crit Care Med. 2021;203:1070–1087.

MeSH terms